The index of tobacco treatment quality: development of a tool to assess evidence-based treatment in a national sample of drug treatment facilities

Table 1 Stratification of sample and comparison to remaining facilities

Cell description	Non-participating N = 3366 (%)	Survey sample N = 405 (%)
1. NRT*, For-Profit, Methadone	12 (0.4)	3 (0.7)
2. NRT, Not For-Profit, Methadone	44 (1.3)	12 (3.0)
3. NRT, Not For-Profit, No Methadone	123 (3.7)	31 (7.77)
4. NRT, For-Profit, No Methadone	35 (1.0)	12 (3.0)
5. No NRT, For-Profit, Methadone	399 (11.9)	45 (11.1)
6. No NRT, Not For-Profit, Methadone	231 (6.9)	27 (6.7)
7. No NRT, Not For-Profit, No Methadone	1442 (42.8)	163 (40.2)
8. No NRT, For-Profit, No Methadone	1080 (32.1)	112 (27.7)

*NRT = Nicotine Replacement Therapy.
** Compared to all U.S. facilities, facilities in our sample were more likely to provide nicotine replacement, more likely to be rural, more likely to be certified by a mental health department, and less likely to be certified or licensed by a state substance abuse treatment facility.

ISSN: 1747-597X